Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$65.08
-0.55-0.84%
At close: -
$65.08
0.000.00%
After Hours: May 9, 4:00 PM EDT
Comments
Loading...
Insmed Analyst Ratings and Price Targets | NASDAQ:INSM | Benzinga
Insmed Inc has a consensus price target of $84.21 based on the ratings of 21 analysts. The high is $109 issued by UBS on May 9, 2025. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by UBS, HC Wainwright & Co., and B of A Securities on May 9, 2025, April 22, 2025, and March 20, 2025, respectively. With an average price target of $98.33 between UBS, HC Wainwright & Co., and B of A Securities, there's an implied 51.10% upside for Insmed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
HC Wainwright & Co.
B of A Securities
RBC Capital
Guggenheim
1calculated from analyst ratings
Analyst Ratings for Insmed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2025 | Buy Now | 67.49% | UBS | Trung Huynh64% | $110 → $109 | Maintains | Buy | Get Alert |
| 04/22/2025 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2025 | Buy Now | 47.51% | B of A Securities | Jason Zemansky72% | $92 → $96 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | 53.66% | RBC Capital | Leonid Timashev38% | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2025 | Buy Now | 69.02% | UBS | Trung Huynh64% | $105 → $110 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 53.66% | RBC Capital | Leonid Timashev38% | → $100 | Initiates | → Outperform | Get Alert |
| 02/25/2025 | Buy Now | 55.19% | Guggenheim | Vamil Divan75% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 65.95% | Truist Securities | Nicole Germino41% | $105 → $108 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 47.51% | Stifel | Stephen Willey49% | $97 → $96 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim45% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim45% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 64.41% | Wells Fargo | Tiago Fauth42% | $85 → $107 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 49.05% | Stifel | Stephen Willey49% | $88 → $97 | Maintains | Buy | Get Alert |
| 02/07/2025 | Buy Now | 41.36% | JP Morgan | Jessica Fye64% | $83 → $92 | Maintains | Overweight | Get Alert |
| 02/07/2025 | Buy Now | 55.19% | Guggenheim | Vamil Divan75% | $95 → $101 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 38.29% | Morgan Stanley | Matthew Harrison60% | $85 → $90 | Maintains | Overweight | Get Alert |
| 11/22/2024 | Buy Now | 27.54% | JP Morgan | Jessica Fye64% | $74 → $83 | Maintains | Overweight | Get Alert |
| 11/01/2024 | Buy Now | 61.34% | Truist Securities | Nicole Germino41% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
| 11/01/2024 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | 53.66% | Truist Securities | Nicole Germino41% | $85 → $100 | Maintains | Buy | Get Alert |
| 10/09/2024 | Buy Now | 32.15% | B of A Securities | Jason Zemansky72% | $84 → $86 | Maintains | Buy | Get Alert |
| 10/03/2024 | Buy Now | 13.71% | JP Morgan | Jessica Fye64% | $72 → $74 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer52% | — | Reiterates | → Overweight | Get Alert |
| 08/29/2024 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 30.61% | Truist Securities | Nicole Germino41% | $88 → $85 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | 50.58% | TD Cowen | Ritu Baral34% | $75 → $98 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 29.07% | UBS | Trung Huynh64% | $78 → $84 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 35.22% | Stifel | Stephen Willey49% | $74 → $88 | Maintains | Buy | Get Alert |
| 07/12/2024 | Buy Now | 30.61% | Morgan Stanley | Matthew Harrison60% | $60 → $85 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 56.73% | Goldman Sachs | Andrea Tan39% | $74 → $102 | Maintains | Buy | Get Alert |
| 07/09/2024 | Buy Now | 45.97% | Guggenheim | Vamil Divan75% | $70 → $95 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 38.29% | HC Wainwright & Co. | Andrew Fein55% | $70 → $90 | Maintains | Buy | Get Alert |
| 07/05/2024 | Buy Now | 27.54% | B of A Securities | Jason Zemansky72% | $83 → $83 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 7.56% | HC Wainwright & Co. | Andrew Fein55% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 07/01/2024 | Buy Now | 35.22% | Truist Securities | Nicole Germino41% | $68 → $88 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 27.54% | B of A Securities | Jason Zemansky72% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | 15.24% | Evercore ISI Group | Josh Schimmer52% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim45% | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | Buy Now | 10.63% | JP Morgan | Jessica Fye64% | $55 → $72 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 26% | Mizuho | Graig Suvannavejh50% | $36 → $82 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 13.71% | Stifel | Stephen Willey49% | $67 → $74 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | 2.95% | Stifel | Stephen Willey49% | $39 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 2.95% | TD Cowen | Ritu Baral34% | $45 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -10.88% | UBS | Trung Huynh64% | $46 → $58 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 13.71% | Goldman Sachs | Andrea Tan39% | $49 → $74 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 18.32% | Wells Fargo | Tiago Fauth42% | $55 → $77 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | 4.49% | Truist Securities | Nicole Germino41% | $48 → $68 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -3.2% | Barclays | Leon Wang65% | $40 → $63 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -15.49% | JP Morgan | Jessica Fye64% | $36 → $55 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -4.73% | B of A Securities | Jason Zemansky72% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 7.56% | HC Wainwright & Co. | Andrew Fein55% | $52 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | -7.81% | Morgan Stanley | Matthew Harrison60% | $43 → $60 | Maintains | Overweight | Get Alert |
| 05/28/2024 | Buy Now | -38.54% | B of A Securities | Jason Zemansky72% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/16/2024 | Buy Now | -26.24% | Truist Securities | Nicole Germino41% | $48 → $48 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | -24.71% | Goldman Sachs | Andrea Tan39% | $40 → $49 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | -20.1% | HC Wainwright & Co. | Andrew Fein55% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | -44.68% | Mizuho | Graig Suvannavejh50% | $35 → $36 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -33.93% | Morgan Stanley | Matthew Harrison60% | $40 → $43 | Maintains | Overweight | Get Alert |
| 04/23/2024 | Buy Now | -26.24% | Truist Securities | Nicole Germino41% | → $48 | Initiates | → Buy | Get Alert |
| 04/11/2024 | Buy Now | -38.54% | Barclays | Leon Wang65% | $37 → $40 | Maintains | Overweight | Get Alert |
| 04/01/2024 | Buy Now | -15.49% | Wells Fargo | Tiago Fauth42% | $55 → $55 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | -17.03% | Guggenheim | Vamil Divan75% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -29.32% | UBS | Trung Huynh64% | → $46 | Initiates | → Buy | Get Alert |
| 02/23/2024 | Buy Now | -38.54% | B of A Securities | Jason Zemansky72% | $37 → $40 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -35.46% | Wolfe Research | Andy Chen36% | → $42 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | -44.68% | JP Morgan | Jessica Fye64% | → $36 | Reinstates | → Overweight | Get Alert |
| 10/27/2023 | Buy Now | -46.22% | Mizuho | Graig Suvannavejh50% | $33 → $35 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -17.03% | Cantor Fitzgerald | Jennifer Kim45% | $46 → $54 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -29.32% | Cantor Fitzgerald | Jennifer Kim45% | → $46 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | Buy Now | -35.46% | Evercore ISI Group | Josh Schimmer52% | $32 → $42 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -49.29% | Mizuho | Graig Suvannavejh50% | $30 → $33 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -43.15% | B of A Securities | Jason Zemansky72% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -20.1% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | Buy Now | -20.1% | Guggenheim | Vamil Divan75% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | -46.22% | Stifel | Stephen Willey49% | $33 → $35 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -37% | Morgan Stanley | Matthew Harrison60% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | -20.1% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2023 | Buy Now | -53.9% | Mizuho | Graig Suvannavejh50% | $28 → $30 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | -23.17% | Guggenheim | Vamil Divan75% | → $50 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | -20.1% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | -29.32% | Cantor Fitzgerald | Jennifer Kim45% | $49 → $46 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | -29.32% | Credit Suisse | Judah Frommer65% | → $46 | Reiterates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | -20.1% | HC Wainwright & Co. | Andrew Fein55% | → $52 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | -46.22% | Barclays | Leon Wang65% | $37 → $35 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | -40.07% | Goldman Sachs | Andrea Tan39% | $44 → $39 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | -56.98% | Mizuho | Graig Suvannavejh50% | → $28 | Initiates | → Buy | Get Alert |
| 12/08/2022 | Buy Now | -43.15% | Barclays | Leon Wang65% | → $37 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | Buy Now | -43.15% | Barclays | Leon Wang65% | → $37 | Initiates | → Overweight | Get Alert |
| 11/18/2022 | Buy Now | -40.07% | B of A Securities | Jason Zemansky72% | → $39 | Initiates | → Buy | Get Alert |
| 10/27/2022 | Buy Now | -23.17% | SVB Leerink | Joseph Schwartz65% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | -24.71% | Cantor Fitzgerald | Jennifer Kim45% | $53 → $49 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -18.56% | Cowen & Co. | Ritu Baral34% | $56 → $53 | Maintains | Outperform | Get Alert |
| 07/15/2022 | Buy Now | -37% | Morgan Stanley | Matthew Harrison60% | $46 → $41 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | -26.24% | Goldman Sachs | Andrea Tan39% | $56 → $48 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Insmed (INSM) stock?
The latest price target for Insmed (NASDAQ:INSM) was reported by UBS on May 9, 2025. The analyst firm set a price target for $109.00 expecting INSM to rise to within 12 months (a possible 67.49% upside). 60 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insmed (INSM)?
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by UBS, and Insmed maintained their buy rating.
When was the last upgrade for Insmed (INSM)?
There is no last upgrade for Insmed
When was the last downgrade for Insmed (INSM)?
There is no last downgrade for Insmed.
When is the next analyst rating going to be posted or updated for Insmed (INSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.
Is the Analyst Rating Insmed (INSM) correct?
While ratings are subjective and will change, the latest Insmed (INSM) rating was a maintained with a price target of $110.00 to $109.00. The current price Insmed (INSM) is trading at is $65.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
